DAFNA Capital Management

DAFNA Capital Management as of March 31, 2023

Portfolio Holdings for DAFNA Capital Management

DAFNA Capital Management holds 72 positions in its portfolio as reported in the March 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p Biotech Etf Etf (XBI) 13.0 $43M 570k 76.21
Stereotaxis Com New (STXS) 8.4 $28M 14M 2.04
Iveric Bio 4.5 $15M 613k 24.33
Ascendis Pharma A/s Sponsored Adr (ASND) 4.3 $15M 135k 107.22
Karuna Therapeutics Ord 4.3 $14M 79k 181.64
Ishares Nasdaq Biotech Indx Etf (IBB) 4.0 $13M 103k 129.16
Revolution Medicines (RVMD) 3.7 $13M 576k 21.66
Blueprint Medicines (BPMC) 3.5 $12M 261k 44.99
Xenon Pharmaceuticals (XENE) 3.4 $11M 316k 35.79
Cytokinetics Com New (CYTK) 2.9 $9.7M 277k 35.19
Syndax Pharmaceuticals (SNDX) 2.8 $9.4M 447k 21.12
Dex (DXCM) 2.4 $7.8M 68k 116.18
Sage Therapeutics (SAGE) 2.3 $7.6M 180k 41.96
Neurocrine Biosciences (NBIX) 2.3 $7.6M 75k 101.22
Morphic Hldg (MORF) 2.0 $6.8M 180k 37.64
Ideaya Biosciences (IDYA) 1.9 $6.4M 468k 13.73
Cardiovascular Systems 1.7 $5.7M 287k 19.86
Dice Therapeutics 1.6 $5.4M 188k 28.65
Viking Therapeutics (VKTX) 1.6 $5.3M 319k 16.65
Merus N V (MRUS) 1.6 $5.2M 284k 18.40
AtriCure (ATRC) 1.6 $5.2M 126k 41.45
Nurix Therapeutics (NRIX) 1.5 $5.0M 567k 8.88
Edgewise Therapeutics (EWTX) 1.5 $4.9M 733k 6.67
Kalvista Pharmaceuticals (KALV) 1.5 $4.8M 616k 7.86
BioCryst Pharmaceuticals (BCRX) 1.4 $4.6M 552k 8.34
Adicet Bio (ACET) 1.4 $4.6M 797k 5.76
Century Therapeutics (IPSC) 1.4 $4.5M 1.3M 3.47
Apellis Pharmaceuticals (APLS) 1.1 $3.8M 58k 65.96
Alector (ALEC) 1.1 $3.7M 592k 6.19
Accuray Incorporated (ARAY) 1.1 $3.6M 1.2M 2.97
Mediwound Shs New (MDWD) 1.0 $3.4M 258k 13.32
Biohaven (BHVN) 1.0 $3.2M 236k 13.66
Arcus Biosciences Incorporated (RCUS) 1.0 $3.2M 175k 18.24
Axogen (AXGN) 0.9 $3.1M 332k 9.45
Mirati Therapeutics 0.8 $2.7M 74k 37.18
Bicycle Therapeutics Sponsored Ads (BCYC) 0.8 $2.6M 122k 21.27
Autolus Therapeutics Spon Ads (AUTL) 0.6 $2.2M 1.2M 1.84
Mersana Therapeutics (MRSN) 0.6 $2.1M 511k 4.11
Galapagos Nv Spon Adr (GLPG) 0.6 $2.0M 53k 38.64
Proqr Therapeutics N V Shs Euro (PRQR) 0.6 $2.0M 941k 2.13
Vigil Neuroscience (VIGL) 0.5 $1.7M 172k 9.79
Kura Oncology (KURA) 0.4 $1.3M 110k 12.23
Iteos Therapeutics (ITOS) 0.4 $1.3M 99k 13.61
Theseus Pharmaceuticals 0.3 $1.2M 131k 8.88
Larimar Therapeutics (LRMR) 0.3 $1.1M 237k 4.53
Oric Pharmaceuticals (ORIC) 0.3 $971k 170k 5.70
Astria Therapeutics (ATXS) 0.3 $929k 70k 13.30
Neuronetics (STIM) 0.3 $913k 314k 2.91
Brainsway Sponsored Ads (BWAY) 0.2 $832k 474k 1.75
Keros Therapeutics (KROS) 0.2 $827k 19k 42.70
Genfit S A Ads (GNFT) 0.2 $812k 198k 4.10
Mereo Biopharma Group Spon Ads (MREO) 0.2 $775k 1.1M 0.71
Surface Oncology 0.2 $769k 1.1M 0.70
Karyopharm Therapeutics (KPTI) 0.2 $750k 193k 3.89
Syros Pharmaceuticals Com New (SYRS) 0.2 $710k 266k 2.67
Spruce Biosciences (SPRB) 0.2 $690k 312k 2.21
Acrivon Therapeutics Common Stock (ACRV) 0.2 $649k 51k 12.69
Pardes Biosciences 0.2 $633k 479k 1.32
Masimo Corporation (MASI) 0.2 $554k 3.0k 184.54
Kinnate Biopharma 0.2 $506k 81k 6.25
Regulus Therapeutics (RGLS) 0.1 $471k 556k 0.85
Medicenna Therapeutics Corp. (MDNAF) 0.1 $416k 660k 0.63
Sutro Biopharma (STRO) 0.1 $391k 85k 4.62
Ikena Oncology (IKNA) 0.1 $390k 113k 3.45
Adaptimmune Therapeutics Sponds Adr (ADAP) 0.1 $383k 351k 1.09
Compass Therapeutics (CMPX) 0.1 $382k 117k 3.27
Nextcure (NXTC) 0.1 $278k 188k 1.48
Lineage Cell Therapeutics In (LCTX) 0.1 $210k 140k 1.50
Inogen (INGN) 0.1 $187k 15k 12.48
Spero Therapeutics (SPRO) 0.1 $181k 125k 1.45
Compugen Ord (CGEN) 0.0 $144k 205k 0.70
Reunion Neuroscience 0.0 $8.7k 13k 0.69